Lidia Gil

Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Jan Styczyński, Lidia Gil, Gloria Tridello et al. · Clinical Infectious Diseases · 2013 · 246 citations · Full text

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation

Stefan Grajek, Małgorzata Popiel, Lidia Gil et al. · European Heart Journal · 2009 · 114 citations

Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study

Jan Styczyński, K Czyźewski, Mariusz Wysocki et al. · Clinical Microbiology and Infection · 2015 · 99 citations · Full text

Transplantation, Marrow Transplantation, Infection-related Mortality +11

Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and Outcome

Lidia Gil, Jan Styczyński, Mieczysław Komarnicki · Infection · 2007 · 96 citations

Transplantation, Marrow Transplantation, Risk Factors Analysis +7

Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study

Jan Styczyński, Adriana Balduzzi, Lidia Gil et al. · Blood · 2011 · 96 citations · Full text